US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (190)
  • Diseases & Conditions (3582)
  • Drug Delivery (174)
  • Therapeutic Area (5638)
  • Vaccines (590)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
10/30/2014 | published by: Kalorama Information
... maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific ...  |  read more...
USD 3,995
Gemzar-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Lucentis-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Revlimid-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Croatia Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... from pharmacies andwholesalers over its pricing policies. We forecast weak pharmaceutical market growth over the nextdecade, in light of Croatia's acceding to EU pressure to rein in its budget deficit. With Croatia's economyremaining in the ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... has also been increased. Thiscontinued expansion, coupled with a high burden of disease, will drive the need for pharmaceuticalproducts providing opportunities for drugmakers. The continued presence of counterfeit drugs andinsufficient healthcare infrastructure are weaknesses of ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... models to market medicines in a country that has traditionally focussed on the treatment ofinfectious diseases such as malaria, tuberculosis and HIV. Besides challenges related to diagnosis, careand treatment, there is a lack of understanding ...  |  read more...
USD 1,295
Slovenia Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... is imminent over the coming monthsin the attempt to bring the budget deficit down. As a result, going into 2015 and 2016 we anticipate that thefocus will remain on local generic drugmakers, with limited opportunities ...  |  read more...
USD 1,295
Thailand Pharmaceuticals and Healthcare Report Q1 2015
11/5/2014 | published by: Business Monitor International
... opportunities though risks stemming from cost containment policies and patent approvaldelays dampen the overall attractiveness. Headline Expenditure Projections Pharmaceuticals: THB142.5bn (USD4.64bn) in 2013 to THB146bn (USD4.49bn) in 2014; +2.49% inlocal currency terms and -3.12% in ...  |  read more...
USD 1,295
Zelitrex-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Vivanza-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Veramyst-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zeffix-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zocor-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zemplar-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Tyverb-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Xyrem-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Allelock-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Ranexa-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Relpax-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Tegrital-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Rapamune-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Bepanthene-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Bonviva-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Urorek-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
< prev 1    3  4  5  6  7  8  9  10